Gabapentin as treatment for hemifacial spasm

European Neurology

Volumn 42, Issue 1, 1999, Pages 49-51

  Bandini, Fabio ^a   Mazzella, Luca ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b NONE

Author keywords

Gabapentin; Hemifacial spasm

Indexed keywords

ANTICONVULSIVE AGENT; BACLOFEN; BOTULINUM TOXIN; GABAPENTIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPRESSION; DECOMPRESSION SURGERY; DRUG EFFICACY; FACE MUSCLE; FACIAL NERVE; FEMALE; HEMIFACIAL SPASM; HUMAN; MALE; PRIORITY JOURNAL; SIDE EFFECT;

ACETIC ACIDS; ADULT; AGED; AMINES; ANTICONVULSANTS; CYCLOHEXANECARBOXYLIC ACIDS; FEMALE; FOLLOW-UP STUDIES; GAMMA-AMINOBUTYRIC ACID; HEMIFACIAL SPASM; HUMANS; MALE; MIDDLE AGED; TIME FACTORS; TREATMENT OUTCOME;

EID: 0033052853     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000008068     Document Type: Article

References (18)

1. Rosner H, Rubin L, Kestenbaum A: Gabapentin adjunctive therapy in neuropathic pain. Clin J Pain 1996;12:56-58.
2. Graul AI: Focus on present and future migraine therapy. Drug News Perspect 1996;9: 560-561.
3. Averbuch-Heller L, Tusa RJ, Fuhry L, Rottach KG, Ganser GL, Heide W, Büttner U, Leigh RJ: A double-blind controlled study of gabapentin and baclofen as treatment for acquired nystagmus. Ann Neurol 1997;41:818-825.
4. Priebe MM, Sherwood AM, Graves DE, Olson WH: Effectiveness of gabapentin in controlling spasticity: A quantitative study. Spinal Cord 1997;35:171-175.
5. Young LT, Robb JC, Patelis-Siotis D, Mac Donald C, Joffe RT: Acute treatment of bipolar depression with gabapentin. Biol Psychiatry 1997;42:851-853.
6. Neilsen VK: Pathophysiology of hemifacial spasm. I. Ephaptic transmission and ectopic excitation. Neurology 1984;34:418-426.
7. Moller AR: Hemifacial spasm: Ephaptic transmission or hyperexcitability of the facial motor nucleus. Exp Neurol 1987;98:110-119.
8. Mellik GA: Hemifacial spasm: Successful treatment with felbamate. J Pain Symptom Manage 1995;10:392-395.
9. Gross ML: Hemifacial spasm: Treatment with pizotifen. J Neurol Neurosurg Psychiatry 1996; 61:118.
10. Brin MF, Jankovic J, Comella C, Blitzer A, Tsui J, Pullman SL: Treatment of dystonia using botulinum toxin; in Kurlan R (ed): Treatment of Movement Disorders, Philadelphia, Lippincott, 1995, pp 183-246.
11. Wirtschafter JD, McLoon LK: Long-term efficacy of local doxorubicin chemomyectomy in patients with blepharospasm and hemifacial spasm. Ophthalmology 1998;105:342-346.
12. Barker FG II, Jannetta PJ, Bissonette DJ, Shields PT, Larkins MV, Jho HD: Microvascular decompression for hemifacial spasm. J Neurosurg 1995;82:201-210.
13. Payner TD, Tew JM : Recurrence of hemifacial spasm after microvascular decompression. Neurosurgery 1996;38:686-690.
14. Illingworth RD, Porter DG, Jakubowski J: Hemifacial spasm: A prospective long-term follow up of 83 cases treated by microvascular decompression at two neurosurgical centres in the United Kingdom. J Neurol Neurosurg Psychiatry 1996;60:72-77.
15. Taylor CP: Gabapentin: Mechanisms of action; in Levy RH, Mattson RH, Meldrum BS (eds): Antiepileptic Drugs. New York, Raven Press, 1995, pp 829-841.
16. Löscher W, Hönack D, Taylor CP: Gabapentin increases aminooxyacetic acid-induced GABA accumulation in several regions of the rat brain. Neurosci Lett 1991;128:150-154.
17. Honmou O, Oyelese AA, Kocsis JD: The anticonvulsant gabapentin enhances promoted release of GABA in hippocampus: A field potential analysis. Brain Res 1995;692:273-277.
18. Patel J, Naritoku DK: Gabapentin for the treatment of hemifacial spasm. Clin Neuropharmacol 1996;19:185-188.